Prostatic carcinoma: limited field irradiation
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
This is a retrospective study of 251 patients with histologically proven adenocarcinoma treated primarily with limited field radiotherapy techniques, under the principle direction of authors JMV and JPG, between 1968 and 1981 in San Francisco, California. All patients are followed for a minimum of 3 years; mean follow-up is 7.3 years. Routine clinical staging procedures included: HandP, digital prostate exam, cystoscopy, biopsy, blood studies including serum acid phosphatase, and imaging studies including chest X ray, IVP, bone survey or radionucleotide bone scan, and in recent years, pelvic CT scans. Twelve patients are Stage A1, 37-Stage A2, 50-Stage B, 140-Stage C1 and 12-Stage C2. Ninety percent of all cases and 85% of Stage C patients were treated with limited fields to the prostate and periprostatic volume only. Total doses were prescribed at midplane or isocenter and were generally 6500-7000 cGy, daily doses of 180-200 cGy, 5 days per week. Actuarial 5- and 10-year survival rates are: entire population-69% and 47%; Stage A1-74% and 50%; Stage A2-81% and 67%; Stage B-84% and 53%; Stage C1-63% and 42%; Stage C2-32% and 11%. The 5- and 10-year disease-free actuarial survivals are: entire population-71% and 50%; Stage A1-89% and 74%; Stage A2-82% and 69%; Stage B-71% and 52%; Stage C1-67% and 44%; Stage C2-0%. Sites of recurrence, alone or as a component of the failure pattern are: 37 (15%) local, 11 (4%) symptomatic regional recurrence (lower extremity edema, pelvic pain/sciatica, hydroureteronephrosis), and 87 (35%) distant metastasis. Seven (3%) had unknown sites of failure. Local-regional failure occurred in 42% of Stage C2 patients.
- Research Organization:
- Children's Hospital, San Francisco, CA
- OSTI ID:
- 6071955
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 13:7; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Stage II endometrial carcinoma. Results and complications of a combined radiotherapeutic-surgical approach
Interstitial gold and external beam irradiation for prostate cancer
External beam radiotherapy for carcinoma of the prostate
Journal Article
·
Fri Apr 15 00:00:00 EDT 1988
· Cancer (Philadelphia); (United States)
·
OSTI ID:6998493
Interstitial gold and external beam irradiation for prostate cancer
Journal Article
·
Sun May 01 00:00:00 EDT 1988
· J. Urol.; (United States)
·
OSTI ID:6969451
External beam radiotherapy for carcinoma of the prostate
Journal Article
·
Thu Jun 15 00:00:00 EDT 1989
· Cancer (Philadelphia); (United States)
·
OSTI ID:5930047
Related Subjects
550601 -- Medicine-- Unsealed Radionuclides in Diagnostics
550602 -- Medicine-- External Radiation in Diagnostics-- (1980-)
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BIOMEDICAL RADIOGRAPHY
BODY
BODY AREAS
CALIFORNIA
CARCINOMAS
COMBINED THERAPY
COMPUTERIZED TOMOGRAPHY
COUNTING TECHNIQUES
DIAGNOSTIC TECHNIQUES
DISEASES
FEDERAL REGION IX
GLANDS
HORMONES
MALE GENITALS
MEDICINE
NEOPLASMS
NORTH AMERICA
NUCLEAR MEDICINE
ORGANS
PATIENTS
PELVIS
POST-IRRADIATION EXAMINATION
PROSTATE
RADIOISOTOPE SCANNING
RADIOLOGY
RADIOTHERAPY
SKELETON
THERAPY
TOMOGRAPHY
USA
550602 -- Medicine-- External Radiation in Diagnostics-- (1980-)
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BIOMEDICAL RADIOGRAPHY
BODY
BODY AREAS
CALIFORNIA
CARCINOMAS
COMBINED THERAPY
COMPUTERIZED TOMOGRAPHY
COUNTING TECHNIQUES
DIAGNOSTIC TECHNIQUES
DISEASES
FEDERAL REGION IX
GLANDS
HORMONES
MALE GENITALS
MEDICINE
NEOPLASMS
NORTH AMERICA
NUCLEAR MEDICINE
ORGANS
PATIENTS
PELVIS
POST-IRRADIATION EXAMINATION
PROSTATE
RADIOISOTOPE SCANNING
RADIOLOGY
RADIOTHERAPY
SKELETON
THERAPY
TOMOGRAPHY
USA